RPL3 and acute myeloid leukemia: In one study aimed at finding druggable gene candidates for AML with high PRL-3, a whole-genome RNAi library screen (80,000 shRNA targeting 16,000 genes) was performed in AML cells co-transduced with an RPL-3 overexpression construct [23].